消除乙型肝炎的全球投资框架
本文利用已发表模型数据和关键利益相关者访谈构建投资框架,以公共卫生方法识别循证国家活动及国际支持,聚焦乙型肝炎,估算消除投资的巨大经济效益并展示到2030年可节省成本。
要点
- WHO设定了2030年消除病毒性肝炎公共卫生威胁的全球目标。
- 当前全球消除规划投资不足以实现目标,需政治承诺和融资。
核心结论
- 聚焦乙型肝炎,本卫生政策论文运用投资框架估算消除乙型肝炎投资的巨大经济效益,并展示此类投资到2030年可节省成本。
研究设计与样本
- 卫生政策论文,利用已发表模型数据和关键利益相关者访谈构建投资框架。
主要发现
- 框架采用公共卫生方法识别减少病毒性肝炎相关发病和死亡的循证国家活动,以及国际活动和关键使能因素。
- 框架在WHO 2030年病毒消除目标背景下,使各国投资对健康结果产生最大影响。
临床怎么用
- 为催化政治承诺并鼓励国内和国际融资,构建投资框架以展示消除病毒性肝炎的投资回报。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: More than 292 million people are living with hepatitis B worldwide and are at risk of death from cirrhosis and liver cancer. The World Health Organization (WHO) has set global targets for the elimination of viral hepatitis as a public health threat by 2030. However, current levels of global investment in viral hepatitis elimination programmes are insufficient to achieve these goals. METHODS: To catalyse political commitment and to encourage domestic and international financing, we used published modelling data and key stakeholder interviews to develop an investment framework to demonstrate the return on investment for viral hepatitis elimination. RESULTS: The framework utilises a public health approach to identify evidence-based national activities that reduce viral hepatitis-related morbidity and mortality, as well as international activities and critical enablers that allow countries to achieve maximum impact on health outcomes from their investments - in the context of the WHO's 2030 viral elimination targets. CONCLUSION: Focusing on hepatitis B, this health policy paper employs the investment framework to estimate the substantial economic benefits of investing in the elimination of hepatitis B and demonstrates how such investments could be cost saving by 2030. LAY SUMMARY: Hepatitis B infection is a major cause of death from liver disease and liver cancer globally. To reduce deaths from hepatitis B infection, we need more people to be tested and treated for hepatitis B. In this paper, we outline a framework of activities to reduce hepatitis B-related deaths and discuss ways in which governments could pay for them.
引用
- Howell J, Pedrana A, Schroeder SE, et al. A global investment framework for the elimination of hepatitis B. J Hepatol. 2020. PMID: 32971137. doi:10.1016/j.jhep.2020.09.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。